Group II phospholipase A2 is not a major modifier of colonic adenomatous polyps in humans

Gastroenterologia Japonica - Tập 32 - Trang 431-432 - 1997
Takeshi Minami1, Shuji Kanayama1, Hiromasa Tojo2, Ikuko Akedo3, Yuji Matsuzawa1
1Second Department of Internal Medicine, Osaka University Medical School, Suita, Japan
2Department of Molecular Physiological Chemistry, Osaka University Medical School, Suita, Japan
3Department of Cancer Epidemiology, The Center for Adult Disease, Osaka, Osaka, Japan

Tài liệu tham khảo

Kudo I, Murakami M, Hara S, et al. Mammalian non-pancreatic phospholipase A2. Biochim Biophys Acta 1993;117:217–231. Minami T, Tojo H, Shinomura Y, et al. Increased group II phospholipase A2 in colonic mucosa of patients with Crohn's disease and ulcerative colitis. Gut 1994;35:1593–1598. Minami T, Tojo H, Shinomura Y, et al. Raised serum activity of phospholipase A2 immunochemically related to group II enzyme in inflammatory bowel disease: Its correlation with disease activity of Crohn's disease and ulcerative colitis. Gut 1992;33:914–921. MacPhee M, Chepenik KP, Liddell RA, et al. The secretory phospholipase A2 gene is a candidate for the Mom 1 locus, a major modifier of APCMin-induced intestinal neoplasia. Cell 1995:81:957–966. Minami T, Tojo H, Shinomura Y, et al. Purification and characterization of a phospholipase A2 from human ileal mucosa. Biochim Biophys Acta 1993;1170:125–130.